Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol Sedation During ERCP
NCT04860167Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Sep 2018
- Primary completion
- Sep 2019
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of propofol, diclofenac and lidocaine 10% oropharyngeal spray in biliary colic (3 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Total dose of propofol required at 2 hours. Started Sep 2018; status: completed.
02
Drugs
propofoldiclofenaclidocaine 10% oropharyngeal spray
03
Conditions
biliary colic
Beyond the preview
Go deeper on NCT04860167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04860167.